Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial
- PMID: 30208601
- PMCID: PMC6164079
- DOI: 10.3390/nu10091284
Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial
Abstract
Background: Antihypertensive drugs affect mineral metabolism, inflammation, and the oxidative state. The aim of this study was to evaluate the effects of antihypertensive monopharmacotherapy with diuretics, β-blockers, calcium antagonists (Ca-antagonists), angiotensin-converting enzyme inhibitors (ACE-I), and angiotensin II receptor antagonists (ARBs) on zinc (Zn), iron (Fe), and copper (Cu) status, parameters of oxidative and inflammatory states, and glucose and lipid metabolism in patients with newly diagnosed primary arterial hypertension (AH).
Methods: Ninety-eight hypertensive subjects received diuretics, β-blockers, Ca-antagonists, ACE-I, or ARB for three months. Zn, Fe, and Cu concentrations were determined in blood, urine, and hair.
Results: A decrease in zinc serum and erythrocyte concentration and an increase in zinc urine concentration were registered after diuretic administration. Ca-antagonists led to a decrease in erythrocyte zinc concentration. A decrease in serum zinc concentration was observed after ACE-I. A decrease in triglyceride serum concentration was noted after ACE-I therapy, and a decrease in tumor necrosis factor-α serum concentration was seen following administration of Ca-antagonists. Hypotensive drugs led to decreases in catalase and superoxide dismutase serum concentrations.
Conclusions: Three-months of monotherapy with diuretics, Ca-antagonists, or ACE-I impairs zinc status in patients with newly diagnosed primary AH. Antihypertensive monopharmacotherapy and zinc metabolism alterations affect lipid metabolism, the oxidative state, and the inflammatory state.
Keywords: antihypertensive pharmacotherapy; mineral metabolism; zinc.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
The influence of antihypertensive drugs on mineral status in hypertensive patients.Eur Rev Med Pharmacol Sci. 2014;18(1):58-65. Eur Rev Med Pharmacol Sci. 2014. PMID: 24452943 Clinical Trial.
-
ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension.Am J Hypertens. 2001 Mar;14(3):241-7. doi: 10.1016/s0895-7061(00)01266-8. Am J Hypertens. 2001. PMID: 11281235 Clinical Trial.
-
Effect of hypotensive therapy combined with modified diet or zinc supplementation on biochemical parameters and mineral status in hypertensive patients.J Trace Elem Med Biol. 2018 May;47:140-148. doi: 10.1016/j.jtemb.2018.02.016. Epub 2018 Feb 18. J Trace Elem Med Biol. 2018. PMID: 29544801 Clinical Trial.
-
Resistant Hypertension: Which Agent?Heart Lung Circ. 2018 Aug;27(8):911-916. doi: 10.1016/j.hlc.2018.02.013. Epub 2018 Mar 1. Heart Lung Circ. 2018. PMID: 29526418 Review.
-
Metabolic effects of antihypertensive drugs.J Hypertens Suppl. 1995 Dec;13(4):S11-7. doi: 10.1097/00004872-199512002-00003. J Hypertens Suppl. 1995. PMID: 8824682 Review.
Cited by
-
Cardiovascular Diseases and Zinc.Biol Trace Elem Res. 2023 Apr;201(4):1615-1626. doi: 10.1007/s12011-022-03292-6. Epub 2022 Jun 8. Biol Trace Elem Res. 2023. PMID: 35672544 Review.
-
Associated Factors of Hypertension in Women and Men in Vietnam: A Cross-Sectional Study.Int J Environ Res Public Health. 2019 Nov 26;16(23):4714. doi: 10.3390/ijerph16234714. Int J Environ Res Public Health. 2019. PMID: 31779236 Free PMC article.
-
Cardiotoxicity of Iron and Zinc and Their Association with the Mitochondrial Unfolded Protein Response in Humans.Int J Mol Sci. 2024 Sep 6;25(17):9648. doi: 10.3390/ijms25179648. Int J Mol Sci. 2024. PMID: 39273594 Free PMC article.
-
Do medicines commonly used by older adults impact their nutrient status?Explor Res Clin Soc Pharm. 2021 Sep 3;3:100067. doi: 10.1016/j.rcsop.2021.100067. eCollection 2021 Sep. Explor Res Clin Soc Pharm. 2021. PMID: 35480616 Free PMC article. Review.
-
Renin-Angiotensin System Inhibitor Usage and Age-Related Macular Degeneration among Hypertensive Patients: Results from the National Health and Nutrition Examination Survey, 2005-2008.J Ophthalmol. 2020 Jun 24;2020:4252031. doi: 10.1155/2020/4252031. eCollection 2020. J Ophthalmol. 2020. PMID: 32676201 Free PMC article.
References
-
- Khedun S.M., Naicker T., Maharaj B. Zinc, hydrochlorothiazide and sexual dysfunction. Cent. Afr. J. Med. 1995;41:312–315. - PubMed
-
- Baykal Y., Yilmaz M.I., Celik T., Gok F., Rehber H., Akay C., Kocar I.H. Effects of antihypertensive agents, alpha receptor blockers, beta blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and calcium channel blockers, on oxidative stress. J. Hypertens. 2003;21:1207–1211. doi: 10.1097/00004872-200306000-00022. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous